RSCM
ANAC

Rock Springs Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Rock Springs Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-177,500
Closed -$9.49M – 142
2016
Q1 		$9.49M Buy
177,500
+100,500
+131% +$7.42M 0.79% 39
2015
Q4 		$8.7M Sell
77,000
-9,000
-10% -$991K 0.66% 52
2015
Q3 		$10.1M Buy
+86,000
New +$11.2M 0.82% 42

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Rock Springs Capital Management's ANAC Position: Q2 2016 in Review

Rock Springs Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 177,500 shares — an estimated $9.49M sold.

Rock Springs Capital Management first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $10.1M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Rock Springs Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Rock Springs Capital Management sold 177,500 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $9.49M.
  • Rock Springs Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
  • Rock Springs Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $10.1M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Rock Springs Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.